ALSP Orchid Acquisition I priced its IPO of 15 million units at $10 each. Units began trading today on the Nasdaq under ALORU. Each consists of one Class A ordinary share and one-half of a warrant.
The offering is expected to close Nov. 23.
ALSP Orchid was formed by Accelerator Life Science Partners. The SPAC intends to target life science companies in North America and Singapore.
Stifel, Nicolaus and Nomura Securities are joint book-running managers of the offering. The underwriters have the option to purchase up to an additional 2.25 million units to cover over-allotments, if any. Read more.
